PCV114 DABIGATRAN ETEXILATE IS COST-SAVING FOR THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS FOLLOWING MAJOR ORTHOPAEDIC SURGERY IN THE NETHERLANDS
Oct 1, 2009, 00:00 AM
10.1016/S1098-3015(10)74641-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)74641-6/fulltext
Section Title :
Section Order :
566
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74641-6&doi=10.1016/S1098-3015(10)74641-6